PBMs’ use of “clawbacks” prompt lawsuits; Merck’s experimental antiviral drug prevents infection; EMA recommends Novartis’ lung-cancer combo drug
Podcast: Adherence: Leveraging Data to Enhance Your Brand’s Ability to Reach Target Patients
September 14, 2016
6:25 pm
In this sponsored podcast, MM&M’s Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.
The co-pay card debate simmers, as payers push back
If you truly understand who your high writers and compliant patients are, you’ll understand when and how to communicate with prospects that look and act like them.
Five things for pharma marketers to know: Monday, December 28, 2015
Amgen reportedly asks Repatha patients seeking financial assistance for personal health information; Valeant faces more scrutiny of business model; the FDA approves new J&J cancer drug
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix